Zacks Investment Research on MSN
Can CorMedix's Melinta acquisition aid growth beyond DefenCath?
CorMedix CRMD took a major step to diversify its revenue base and lessen reliance on its lead marketed product, DefenCath ...
Naltrexone has long been used to treat alcohol use disorder. Now it’s gaining attention as a tool for people who want to cut ...
Welcome to Start TODAY. Sign up for our free Start TODAY newsletter to receive daily workouts and inspiration sent to your inbox. Then, join us on the Start TODAY Facebook group for tips and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback